Cardiomyopathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with ischemic cardiomyopathy (heart muscle damage caused by reduced blood flow to the heart)
- People who have been diagnosed with dilated cardiomyopathy (a condition where the heart becomes enlarged and cannot pump blood effectively)
- People who have been diagnosed with hypertrophic cardiomyopathy (a condition where the heart muscle becomes abnormally thick)
- People who have been diagnosed with restrictive cardiomyopathy (a condition where the heart muscle becomes stiff and cannot fill with blood properly)
Who may not be able to join:
- Women who are currently pregnant
- Women who are currently breastfeeding
- People who are under legal protection or guardianship (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Gilles BARONE-ROCHETTE, PI, University Hospital, Grenoble
Phone: 0033476766652
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Major Adverse Cardiovascular Events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.